Teladoc Health (NYSE:TDOC) CEO Charles Divita III Sells 17,138 Shares

Teladoc Health, Inc. (NYSE:TDOC) CEO Charles Divita III sold 17,138 shares of Teladoc Health stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $7.63, for a total value of $130,762.94. Following the sale, the chief executive officer directly owned 201,036 shares of the company’s stock, valued at $1,533,904.68. This trade represents a 7.86% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Teladoc Health Stock Performance

NYSE:TDOC traded down $0.05 during midday trading on Thursday, hitting $7.64. The company’s stock had a trading volume of 2,885,549 shares, compared to its average volume of 6,958,736. Teladoc Health, Inc. has a fifty-two week low of $6.35 and a fifty-two week high of $15.21. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.70 and a quick ratio of 2.60. The firm has a market cap of $1.36 billion, a P/E ratio of -5.97 and a beta of 2.04. The firm’s 50 day moving average is $7.99 and its 200-day moving average is $7.78.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.05. The business had revenue of $626.44 million for the quarter, compared to the consensus estimate of $625.66 million. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. The business’s revenue for the quarter was down 2.2% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.19) EPS. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. Equities analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Teladoc Health

A number of large investors have recently added to or reduced their stakes in TDOC. National Bank of Canada FI grew its position in shares of Teladoc Health by 79.4% in the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 1,581 shares during the period. IFP Advisors Inc raised its position in shares of Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after purchasing an additional 3,210 shares during the last quarter. SVB Wealth LLC purchased a new position in Teladoc Health in the 1st quarter valued at about $37,000. Aster Capital Management DIFC Ltd boosted its holdings in Teladoc Health by 101.1% in the 3rd quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock worth $37,000 after buying an additional 2,425 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S acquired a new stake in Teladoc Health in the 1st quarter worth about $50,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have weighed in on TDOC shares. Evercore ISI reduced their price objective on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a research note on Thursday, October 30th. Bank of America dropped their target price on Teladoc Health from $9.00 to $8.00 and set a “neutral” rating on the stock in a report on Tuesday, November 25th. Zacks Research downgraded Teladoc Health from a “strong-buy” rating to a “hold” rating in a report on Monday, November 10th. Weiss Ratings restated a “sell (e+)” rating on shares of Teladoc Health in a research report on Monday. Finally, Barclays began coverage on shares of Teladoc Health in a research note on Tuesday. They set an “equal weight” rating and a $8.50 price objective on the stock. Five equities research analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $9.60.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.